Seeing Is Believing
Currently, out of the existing stock ratings of Mani Foroohar - 108 which are a Buy (52.17%), 82 which are a Hold (39.61%), 17 which are a Sell (8.21%)
Analyst Mani Foroohar works at LEERINK and is covering the Healthcare sector with 414 price targets and ratings displayed on 25 stocks.
Mani Foroohar's average stock forecast success ratio is 35.03% with an average time for price targets to be met of 144.24 days.
Most recent stock forecast was given on ARWR, Arrowhead Pharmaceuticals at 12-May-2023.
Analyst best performing recommendations are on FDMT.
The best stock recommendation documented was for FDMT at 11/14/2022. The price target of $15 was fulfilled within 1 day with a profit of $1.51 (11.19%) receiving and performance score of 111.93.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
6
$4.39 (272.67%)
4
16 days ago
4/7 (57.14%)
$1.84 (83.32%)
24
Hold
4
$2.39 (148.45%)
2
1 months 10 days ago
1/3 (33.33%)
$1.46 (113.82%)
243
Hold
2
$0.39 (24.22%)
5
2 years 1 months 29 days ago
3/5 (60%)
$3.07 (29.73%)
47
Hold
21
2 years 1 months 29 days ago
2/2 (100%)
$7.53 (88.83%)
197
Hold
3
$1.39 (86.34%)
17
2 years 1 months 29 days ago
1/2 (50%)
$2.74 (33.46%)
7
Which stock is Mani Foroohar is most bullish on?
Which stock is Mani Foroohar is most reserved on?
What Year was the first public recommendation made by Mani Foroohar?